Arginine to Lysine Mutations Increase the Aggregation Stability of a Single-Chain Variable Fragment through Unfolded-State Interactions.


Journal

Biochemistry
ISSN: 1520-4995
Titre abrégé: Biochemistry
Pays: United States
ID NLM: 0370623

Informations de publication

Date de publication:
13 08 2019
Historique:
pubmed: 18 7 2019
medline: 6 6 2020
entrez: 18 7 2019
Statut: ppublish

Résumé

Increased protein solubility is known to correlate with an increase in the proportion of lysine over arginine residues. Previous work has shown that the aggregation propensity of a single-chain variable fragment (scFv) does not correlate with its conformational stability or native-state protein-protein interactions. Here, we test the hypothesis that aggregation is driven by the colloidal stability of partially unfolded states, studying the behavior of scFv mutants harboring single or multiple site-specific arginine to lysine mutations in denaturing buffers. In 6 M guanidine hydrochloride (GdmCl) or 8 M urea, repulsive protein-protein interactions were measured for the wild-type and lysine-enriched (4RK) scFvs reflecting weakened short-range attractions and increased excluded volume. In contrast to the arginine-enriched mutant (7KR) scFv exhibited strong reversible association. In 3 M GdmCl, the minimum concentration at which the scFvs were unfolded, the hydrodynamic radius of 4RK remained constant but increased for the wild type and especially for 7KR. Studies of single-point arginine to lysine scFv mutants indicated that the observed aggregation propensity of arginine under denaturing conditions was nonspecific. Interestingly, one such swap generated a scFv with especially low aggregation rates under low/high ionic strengths and denaturing buffers; molecular modeling identified hydrogen bonding between the arginine side chain and main chain peptide groups, stabilizing the structure. The arginine/lysine ratio is not routinely considered in biopharmaceutical scaffold design or current amyloid prediction methods. This work therefore suggests a simple method for increasing the stability of a biopharmaceutical protein against aggregation.

Identifiants

pubmed: 31314511
doi: 10.1021/acs.biochem.9b00367
doi:

Substances chimiques

Protein Aggregates 0
Single-Chain Antibodies 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3413-3421

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L006391/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M006913/1
Pays : United Kingdom

Auteurs

James I Austerberry (JI)

Faculty of Biology, Medicine and Health , University of Manchester , Manchester M13 9PT , United Kingdom.
Manchester Institute of Biotechnology , University of Manchester , Manchester M1 7DN , United Kingdom.

Angela Thistlethwaite (A)

Faculty of Biology, Medicine and Health , University of Manchester , Manchester M13 9PT , United Kingdom.

Karl Fisher (K)

Manchester Institute of Biotechnology , University of Manchester , Manchester M1 7DN , United Kingdom.

Alexander P Golovanov (AP)

Manchester Institute of Biotechnology , University of Manchester , Manchester M1 7DN , United Kingdom.
School of Chemistry , University of Manchester , Manchester M1 7DN , United Kingdom.

Alain Pluen (A)

Manchester Pharmacy School , University of Manchester , Manchester M13 9PL , United Kingdom.

Reza Esfandiary (R)

Dosage Form Design & Development , AstraZeneca , Gaithersburg , Maryland 20878 , United States.

Christopher F van der Walle (CF)

Dosage Form Design & Development , AstraZeneca , Granta Park , Cambridge CB21 6GH , United Kingdom.

Jim Warwicker (J)

Manchester Institute of Biotechnology , University of Manchester , Manchester M1 7DN , United Kingdom.
School of Chemistry , University of Manchester , Manchester M1 7DN , United Kingdom.

Jeremy P Derrick (JP)

Faculty of Biology, Medicine and Health , University of Manchester , Manchester M13 9PT , United Kingdom.

Robin Curtis (R)

Manchester Institute of Biotechnology , University of Manchester , Manchester M1 7DN , United Kingdom.
School of Chemical Engineering and Analytical Science , University of Manchester , Manchester M1 7DN , United Kingdom.

Articles similaires

T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

Prevalence and implications of fragile X premutation screening in Thailand.

Areerat Hnoonual, Sunita Kaewfai, Chanin Limwongse et al.
1.00
Humans Fragile X Mental Retardation Protein Thailand Male Female
Humans Receptors, Antigen, T-Cell Proto-Oncogene Proteins p21(ras) Pancreatic Neoplasms T-Lymphocytes

Classifications MeSH